| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8757525 | Contemporary Clinical Trials | 2018 | 7 Pages |
Abstract
Pharmacogenetic-guided opioid selection for cancer pain management has potential clinical utility, but current evidence is limited to retrospective and observational studies. Precision Medicine Guided Treatment for Cancer Pain is a pragmatic clinical trial that seeks to determine the utility of CYP2D6 genotype-guided opioid prescribing in patients with cancer.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Scott A. Mosley, J.Kevin Hicks, Diane G. Portman, Kristine A. Donovan, Priya Gopalan, Jessica Schmit, Jason Starr, Natalie Silver, Yan Gong, Taimour Langaee, Michael Clare-Salzler, Petr Starostik, Young D. Chang, Sahana Rajasekhara, Joshua E. Smith,